India’s Troubled Ranbaxy Finds a Buyer - Presented by: The Aol. On Network

The proposed sale of Ranbaxy Laboratories to Sun Pharmaceutical closes a troubled chapter for the Indian generic drug maker’s owner, Japan’s Daiichi Sankyo. If the deal is successful, Sun and Ranbaxy will continue to face tough U.S. regulatory measures. Heard on the Street columnists Abheek Bhattacharya, Alex Frangos and Aaron Back discuss the deal’s specifics.



Related Videos

Most Popular Videos

Latest Videos


Most Active by Volume

Company Last Sale Change Net / %
AAPL $ 113.99 1.98 ▲ 1.77%
BAC $ 17.98 unch
RAD $ 7.41 0.15 ▲ 2.07%
PBR $ 7.39 0.21 ▼ 2.76%
ARCP $ 8.30 0.03 ▼ 0.36%
GRPN $ 8.14 0.25 ▲ 3.17%
GILD $ 93.79 2.50 ▲ 2.74%
GE $ 25.78 0.05 ▼ 0.19%

As of 12/26/2014, 04:15 PM
More Most Active

Latest News Headlines

View All